Literature DB >> 17586787

Comparison of older patients with bipolar disorder and schizophrenia/schizoaffective disorder.

Sanjay Gupta1, Charles H Steinmeyer, Kari Lockwood, Barbara Lentz, Kay Schultz.   

Abstract

OBJECTIVE: The aim of this cross-sectional study was to explore differences in measures of symptoms and cognition, side effects, and functional impairment between older patients with schizophrenia and bipolar disorder.
METHODS: Representative samples (N = 132) of older patients (age >54 years) with either bipolar disorder or schizophrenia and schizoaffective disorder were compared on several clinical and psychosocial variables. The measures used included the Brief Psychiatric Rating Scale, The Scale for the Assessment of Negative Symptoms, the Geriatric Depression Scale, the Abnormal Involuntary Movement Scale, the Clinical Global Impression, and the Mini-Mental Status Examination.
RESULTS: Despite being similar in age (mean age: 68 years), patients with schizophrenia/schizoaffective disorder had significantly greater negative symptoms (Cohen's d = 1.2), a higher clinical global impression of impairment (Cohen's d = 1.16), were less likely to drive (Cohen's d = 0.79), were less likely to be married (Cohen's d = 0.55), and less likely to live independently (Cohen's d = 0.45).
CONCLUSION: Although the absolute ratings suggested both diagnostic samples had significant disability, those with schizophrenia and schizoaffective disorder had a greater degree of impairment.

Entities:  

Mesh:

Year:  2007        PMID: 17586787     DOI: 10.1097/JGP.0b013e318065b06b

Source DB:  PubMed          Journal:  Am J Geriatr Psychiatry        ISSN: 1064-7481            Impact factor:   4.105


  6 in total

Review 1.  Pharmacological and clinical profile of recently approved second-generation antipsychotics: implications for treatment of schizophrenia in older patients.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Drugs Aging       Date:  2012-10       Impact factor: 3.923

2.  Age and remission of personality pathology in the psychotic disorders compared to mood and/or anxiety disorders.

Authors:  Tianhong Zhang; Mary-Jo D Good; Byron J Good; Annabelle Chow; Lanlan Wang; Yunfei Dai; Zeping Xiao
Journal:  Int J Psychiatry Med       Date:  2012       Impact factor: 1.210

Review 3.  Co-occurring depressive symptoms in the older patient with schizophrenia.

Authors:  John W Kasckow; Sidney Zisook
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 4.  Aripiprazole for late-life schizophrenia.

Authors:  Jeffrey Rado; Philip G Janicak
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

5.  Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder.

Authors:  John O Brooks; Jennifer C Hoblyn; Stephanie A Woodard; Allyson C Rosen; Terence A Ketter
Journal:  J Psychiatr Res       Date:  2008-10-22       Impact factor: 4.791

6.  A group ICA based framework for evaluating resting fMRI markers when disease categories are unclear: application to schizophrenia, bipolar, and schizoaffective disorders.

Authors:  Yuhui Du; Godfrey D Pearlson; Jingyu Liu; Jing Sui; Qingbao Yu; Hao He; Eduardo Castro; Vince D Calhoun
Journal:  Neuroimage       Date:  2015-07-26       Impact factor: 6.556

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.